ARIAD Pharmaceuticals (NYSE: ARIA), a Cambridge, MA-based global oncology company, inked a pre-lease deal for an additional 142,000 square feet at the Alexandria Center at Kendall Square.
ARIAD Pharmaceuticals (NYSE: ARIA), a Cambridge, MA-based global oncology company, inked a pre-lease deal for an additional 142,000 square feet at the Alexandria Center at Kendall Square.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In